Science, Space and Technology News 2023
The inclusion of glucagon-like peptide-1 receptor agonists in widely used weight loss medications such as Ozempic and Wegovy may pose a potential risk to children’s health., comprising clinicians, exercise scientists, pharmaceutical scholars, ethicists, and behavioral specialists, have raised concerns regarding the use of glucagon-like peptide-1 receptor agonists to treat childhood obesity and type 2 diabetes.led by Dr. Dan M.
“Our major concern is the unbalance and inappropriate reductions in calorie or energy intake associated with these weight loss drugs,” said Cooper, associate director of the UCI Institute for Clinical and Translational Science and interim director of the UCI Institute for Precision Health. “Unlike in adults, children and adolescents need energy and sufficient calories not only for physical activity, but for growth and development.
With the growing efficacy and popularity of these medications, drug manufacturers are quickly developing oral forms of the drugs, which researchers believe could limit oversight and cause cases of abuse. Anecdotal clinical experience suggests that there is already widespread knowledge in the pediatric population about the GLP-1RA’s effectiveness as satiety medications aiding weight loss, not helped by the apparent widespread use documented in the popular media.
As a result of their research and clinical experience with exercise, diet, and obesity prevention, the UCI team outlined a call-to-action. Targeting thenetwork of academic centers, like UCI, that are recipients of Clinical and Translational Science Award hubs across the nation, the call-to-action includes:
Engage and improve the quality and accessibility of relevant real-world data such as school-based physical fitness testing , mandated in 16 states covering around 60% of American school children.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk, Lilly see insatiable demand for weight-loss drugsNovo Nordisk (NOVOb.CO) and Eli Lilly (LLY.N) both expect juggernaut sales for their diabetes and weight-loss drugs to extend into coming years - limited only by their availability.
Read more »
Weight Loss Success: Couple Loses 190 Pounds TogetherA. Pawlowski is a TODAY health reporter focusing on health news and features. Previously, she was a writer, producer and editor at CNN.
Read more »
Crunches are pointless, expert says — how to lose weight the right wayExercise is not a “one size fits all”. Ask any other personal trainer and they’ll tell you to do something different, but there are some moves they try to avoid altogether, like the American kettlebell swing. Buzz60 has more.
Read more »
People Are 'Food Sequencing' for Weight Loss & Swear by the ResultsYour ultimate source for expert nutrition tips and health advice, covering wellness, healthy recipes, cooking hacks, food news, style trends and shopping.
Read more »
Intermittent Fasting Tips: 16:8 Diet for Weight LossA. Pawlowski is a TODAY health reporter focusing on health news and features. Previously, she was a writer, producer and editor at CNN.
Read more »
In 'Beyond Utopia,' the weight of North Korean oppression on its citizenry is undeniableChronicling some dangerous defection attempts, Madeleine Gavin's documentary shows the desperation of those attempting to flee Kim Jong Un's frightening regime.
Read more »